Skip to main content
Premium Trial:

Request an Annual Quote

LineaGen's MS, Autism Diagnostics Project Using Affy Arrays

NEW YORK (GenomeWeb News) – Researchers at the University of Utah and Vanderbilt University are using Affymetrix’s genotyping arrays along with LineaGen’s biomarker diagnostics technology to hunt for genetic markers that could be used in the treatment and diagnosis of multiple sclerosis and autism, Affymetrix and LineaGen jointly announced today.
 
In a project funded and managed by Salt Lake City-based LineaGen, the scientists are using Affy’s Genome-Wide Human SNP Array 6.0 to analyze data from the Utah Population Database to compare genetic information with “decades’ worth of longitudinal clinical data,” the firms said.
 
The researchers expect the study will lead to enhanced understanding of these two diseases, more effective use of existing treatments, and the development of molecular diagnostics and therapies.
 
The Affy arrays will be run at the Vanderbilt Microarray Shared Resource at Vanderbilt University Medical Center.
 
“We have a valuable and unique genetic population resource at the University of Utah and now we can cost-effectively conduct larger-scale studies to determine the genetic associations of common diseases like MS and autism," Mark Leppert, co-chair of the University of Utah’s department of human genetics, said in a statement.
 
Financial terms of the agreement were not released.

The Scan

Study Tracks Off-Target Gene Edits Linked to Epigenetic Features

Using machine learning, researchers characterize in BMC Genomics the potential off-target effects of 19 computed or experimentally determined epigenetic features during CRISPR-Cas9 editing.

Coronary Artery Disease Risk Loci, Candidate Genes Identified in GWAS Meta-Analysis

A GWAS in Nature Genetics of nearly 1.4 million coronary artery disease cases and controls focused in on more than 200 candidate causal genes, including the cell motility-related myosin gene MYO9B.

Multiple Sclerosis Contributors Found in Proteome-Wide Association Study

With a combination of genome-wide association and brain proteome data, researchers in the Annals of Clinical and Translational Neurology tracked down dozens of potential multiple sclerosis risk proteins.

Quality Improvement Study Compares Molecular Tumor Boards, Central Consensus Recommendations

With 50 simulated cancer cases, researchers in JAMA Network Open compared molecular tumor board recommendations with central consensus plans at a dozen centers in Japan.